X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (398) 398
index medicus (336) 336
uveomeningoencephalitic syndrome - drug therapy (317) 317
female (279) 279
adult (248) 248
male (240) 240
uveomeningoencephalitic syndrome - diagnosis (215) 215
ophthalmology (201) 201
middle aged (179) 179
fluorescein angiography (124) 124
glucocorticoids - therapeutic use (122) 122
adolescent (105) 105
uveomeningoencephalitic syndrome - complications (105) 105
visual acuity (96) 96
uveitis (94) 94
retrospective studies (91) 91
vogt-koyanagi-harada disease (84) 84
tomography, optical coherence (71) 71
treatment outcome (66) 66
aged (65) 65
immunosuppressive agents - therapeutic use (65) 65
child (61) 61
follow-up studies (60) 60
uveomeningoencephalitic syndrome - physiopathology (56) 56
drug therapy, combination (54) 54
disease (53) 53
prednisolone - therapeutic use (52) 52
recurrence (52) 52
diagnosis, differential (50) 50
glucocorticoids - administration & dosage (50) 50
abridged index medicus (48) 48
young adult (47) 47
fundus oculi (46) 46
therapy (44) 44
corticosteroids (43) 43
medicine & public health (43) 43
uveitis - drug therapy (43) 43
adrenal cortex hormones - therapeutic use (42) 42
retinal detachment - diagnosis (37) 37
retinal detachment - drug therapy (37) 37
eye diseases (35) 35
meningoencephalitis (35) 35
acute disease (33) 33
methylprednisolone - therapeutic use (33) 33
inflammation (32) 32
retinal detachment - etiology (32) 32
anti-inflammatory agents - therapeutic use (31) 31
uveitis - diagnosis (31) 31
vogt-koyanagi-harada syndrome (31) 31
uveomeningoencephalitic syndrome - immunology (30) 30
uveomeningoencephalitic syndrome - pathology (30) 30
administration, oral (29) 29
prognosis (29) 29
visual acuity - physiology (29) 29
methylprednisolone - administration & dosage (27) 27
prednisone - therapeutic use (27) 27
vogt–koyanagi–harada disease (26) 26
prednisolone - administration & dosage (25) 25
optical coherence tomography (23) 23
care and treatment (22) 22
diagnosis (22) 22
medical colleges (22) 22
uveomeningoencephalitic syndrome - etiology (21) 21
chronic disease (20) 20
cyclosporine - therapeutic use (20) 20
dose-response relationship, drug (19) 19
indocyanine green (19) 19
infusions, intravenous (18) 18
magnetic resonance imaging (18) 18
child, preschool (17) 17
choroid - pathology (17) 17
indocyanine green angiography (17) 17
nomenclature (17) 17
drug therapy (16) 16
tomography (16) 16
uveomeningoencephalitic syndrome - epidemiology (16) 16
clinical neurology (15) 15
features (15) 15
health aspects (15) 15
immunosuppressive agents - administration & dosage (15) 15
injections, intravenous (15) 15
prednisone - administration & dosage (15) 15
prospective studies (15) 15
sunset glow fundus (15) 15
association (14) 14
coloring agents (14) 14
corticosteroid (14) 14
development and progression (14) 14
time factors (14) 14
uveitis - etiology (14) 14
vogt-koyanagi-harada (14) 14
immunology (13) 13
medicine, general & internal (13) 13
retinal diseases - diagnosis (13) 13
uveomeningoencephalitic syndrome - diagnostic imaging (13) 13
glaucoma (12) 12
medical imaging (12) 12
prognostic-factors (12) 12
pulse therapy, drug (12) 12
research (12) 12
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (327) 327
French (22) 22
Japanese (10) 10
German (9) 9
Spanish (9) 9
Chinese (5) 5
Portuguese (5) 5
Russian (3) 3
Italian (2) 2
Norwegian (2) 2
Polish (2) 2
Czech (1) 1
Hebrew (1) 1
Hungarian (1) 1
Romanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Clinical Immunology, ISSN 1521-6616, 2010, Volume 139, Issue 2, pp. 177 - 184
Abstract We assayed aqueous humor (AH) samples from patients with Behçet's disease (BD), Vogt–Koyanagi–Harada (VKH) disease, and HLA-B27-associated uveitis and... 
Allergy and Immunology | Behçet's disease | Vogt–Koyanagi–Harada disease | Cytokines | HLA-B27 | Uveitis | Vogt-Koyanagi-Harada disease | Behcet's disease | EXPERIMENTAL AUTOIMMUNE UVEORETINITIS | BEHCETS-DISEASE | INTERLEUKIN-10 | IMMUNOLOGY | ENDOTOXIN-INDUCED UVEITIS | NOMENCLATURE | INHIBITION | IL23R-IL12RB2 | EXPRESSION | GENOME-WIDE ASSOCIATION | TH17 CELLS | Tumor Necrosis Factor-alpha - metabolism | Cyclosporine - pharmacology | Humans | Middle Aged | Male | Interferon-gamma - metabolism | Adrenal Cortex Hormones - therapeutic use | Th1 Cells - immunology | Aqueous Humor - metabolism | Th1 Cells - metabolism | Young Adult | Uveomeningoencephalitic Syndrome - immunology | Th17 Cells - metabolism | Interleukin-10 - metabolism | Adult | Female | Behcet Syndrome - metabolism | Uveitis - metabolism | Uveitis - diagnosis | Cytokines - metabolism | Uveitis - drug therapy | Uveomeningoencephalitic Syndrome - metabolism | Adrenal Cortex Hormones - pharmacology | Behcet Syndrome - drug therapy | Logistic Models | Treatment Outcome | Uveomeningoencephalitic Syndrome - diagnosis | Cyclosporine - therapeutic use | Interleukin-17 - metabolism | Uveitis - immunology | Interleukin-15 - metabolism | Adolescent | Cyclosporine - administration & dosage | Th17 Cells - immunology | Behcet Syndrome - diagnosis | Uveitis - genetics | Aqueous Humor - drug effects | Behcet Syndrome - immunology | HLA-B27 Antigen - genetics | Adrenal Cortex Hormones - administration & dosage | Histocompatibility antigens | Ophthalmology | Biological response modifiers | HLA histocompatibility antigens | Index Medicus
Journal Article
Journal Article
Acta Ophthalmologica, ISSN 1755-375X, 12/2012, Volume 90, Issue 8, pp. e603 - e608
Purpose:  To study the effectiveness of mycophenolate mofetil (MMF) as first‐line therapy combined with systemic corticosteroids in acute uveitis associated... 
recurrence | Vogt–Koyanagi–Harada disease | mycophenolate mofetil | complications | immunomodulatory therapy | Vogt-Koyanagi-Harada disease | CELLS | SUNSET GLOW FUNDUS | PROGNOSTIC-FACTORS | EFFICACY | AGENT | NOMENCLATURE | INFLAMMATION | OPHTHALMOLOGY | DURATION | Glucocorticoids - administration & dosage | Glucocorticoids - therapeutic use | Prospective Studies | Follow-Up Studies | Methylprednisolone - therapeutic use | Coloring Agents | Humans | Immunosuppressive Agents - therapeutic use | Male | Secondary Prevention | Young Adult | Uveitis, Posterior - diagnosis | Adult | Female | Drug Therapy, Combination | Child | Visual Acuity - physiology | Fluorescein Angiography | Uveitis, Posterior - etiology | Acute Disease | Prednisone - administration & dosage | Administration, Oral | Indocyanine Green | Ophthalmoscopy | Treatment Outcome | Uveomeningoencephalitic Syndrome - drug therapy | Uveitis, Posterior - drug therapy | Uveomeningoencephalitic Syndrome - diagnosis | Uveomeningoencephalitic Syndrome - complications | Mycophenolic Acid - analogs & derivatives | Mycophenolic Acid - therapeutic use | Adolescent | Infusions, Intravenous | Prednisone - therapeutic use | Methylprednisolone - administration & dosage | Prednisone | Corticosteroids | Mycophenolate mofetil | Ophthalmology | Health aspects | Uveitis | Disease | Drug therapy | Index Medicus
Journal Article
Acta Ophthalmologica, ISSN 1755-375X, 02/2017, Volume 95, Issue 1, pp. 85 - 90
Journal Article
Investigative Ophthalmology & Visual Science, ISSN 0146-0404, 07/2012, Volume 53, Issue 8, pp. 4668 - 4675
Journal Article